{
    "2021-10-22": [
        [
            {
                "time": "2021-10-01",
                "original_text": "泰格医药三季度净利润增长35%，葛兰三季度加仓138万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季度",
                        "净利润",
                        "增长",
                        "葛兰",
                        "加仓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药：前三财季盈利17.81亿元人民币，同比增长35.13%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "前三财季",
                        "盈利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "【港股通】泰格医药(03347)前九个月净利润为17.81亿元 同比增长35.13%",
                "features": {
                    "keywords": [
                        "港股通",
                        "泰格医药",
                        "前九个月",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "药明康德、药明生物、泰格…中国CXO高速增长的秘密",
                "features": {
                    "keywords": [
                        "药明康德",
                        "药明生物",
                        "泰格",
                        "CXO",
                        "高速增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药发布2021年第三季度报告",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "2021年",
                        "第三季度",
                        "报告"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药公布三季报 前三季净利增加35.13%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季报",
                        "前三季",
                        "净利",
                        "增加"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药凭什么领涨CRO？",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "领涨",
                        "CRO"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "图解泰格医药三季报：第三季度单季净利润同比增64.80%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季报",
                        "第三季度",
                        "单季",
                        "净利润",
                        "同比增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药(300347.SZ)前三季度归母净利同比增长35.13%至17.81亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "前三季",
                        "归母净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药：三季度净利5.26亿元，同比增长64.80%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "三季度",
                        "净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药(300347.SZ)第三季度净利润5.26亿元 同比增长64.80%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "第三季度",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药：第三季度净利5.26亿元 同比增64.8%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "第三季度",
                        "净利",
                        "同比增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "泰格医药：前三季度净利润同比增长35.13%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "前三季度",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}